Navigation Links
Be One of the First to Experience the New Medtrack Platform at BIO®-Europe 2011

SCRANTON, Pa., Oct. 20, 2011 /PRNewswire/ -- Medtrack is pleased to announce we will debut One View at BIO-Europe 2011. Attendees of the show will be the first to have the opportunity to gain first-hand experience with the newly designed platform. With deeply integrated datasets and new, robust analytic capabilities, Medtrack will provide professionals in business development, competitive intelligence and sales and marketing more comprehensive, actionable information, in an easy to use format. Be sure to visit Medtrack at booth 55, and see how we can help with your critical business decisions.

In preparation for the launch of the new platform and in response to client feedback we are strengthening our global presence by adding client service resources and experienced industry analysts to the Medtrack team to continue to provide our clients with timely expert analysis and best-in-class customer support.

About BIO-Europe 2011

From October 31st to November 2nd, the world's life science leaders and dealmakers will gather in Duesseldorf, Germany for BIO-Europe 2011. BIO-Europe 2011 is Europe's largest partnering event serving the global biotechnology industry. The three-day conference will host more than 3,000 attendees representing about 1,800 companies who will engage in more than 15,000 one-to-one meetings.

About Medtrack

Medtrack is the leader in commercial and scientific intelligence for the life-science industry. Medtrack combines a multitude of datasets into a single, integrated platform that allows clients to quickly search and analyze data. With Medtrack, you will spend less time looking for information, and more time supporting the strategic decisions that are critical to your business. To find out more about Medtrack go to

Contact for further information, call:
Carolle St. Fleur
Tel: 978-664-4498

SOURCE Medtrack
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. MEDRAD Installs First Intego(TM) PET Infusion System
3. Pioneering IVF Technique Produces Region's First Pregnancy
4. Immtech Reports Fiscal First Quarter 2009 Results
5. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
6. Huifeng Bio-Pharmaceutical (HFGB) Reports over $5 Million in Gross Sales; Record Results for the First Half of 2008
7. China-Biotics, Inc. Reports First Quarter 2009 Financial Results
8. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
9. Natures Premium(R) Brand First Fresh Pork in North America to Carry DNA TraceBack(R) Seal of Authenticity
10. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
11. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
Post Your Comments:
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):